<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on BioVentures%2C Inc. from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated BioVentures%2C Inc. news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 02:05:56 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=BioVentures%2C+Inc." rel="self" type="application/rss+xml" />

	
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024549&amp;HITNO=0&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024549&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528986138%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024549&amp;HITNO=0&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024549&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528986138%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>TenX Biopharma acquires exclusive global rights to zanolimumab from Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018675&amp;HITNO=1&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018675&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525874406%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018675&amp;HITNO=1&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018675&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525874406%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Genmab out-licenses global rights for zanolimumab to TenX Biopharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4020693&amp;HITNO=2&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4020693&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526953667%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4020693&amp;HITNO=2&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4020693&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526953667%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Letter:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016248&amp;HITNO=3&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016248&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524689330%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016248&amp;HITNO=3&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016248&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524689330%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
<item><title>Genmab Outlicenses Zanolimumab to TenX Biopharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015511&amp;HITNO=4&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015511&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524427581%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015511&amp;HITNO=4&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015511&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524427581%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Genmab Outlicenses Zanolimumab to TenX Biopharma</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014846&amp;HITNO=5&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014846&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524178976%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014846&amp;HITNO=5&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014846&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524178976%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>EuroInvestor.co.uk:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017230&amp;HITNO=6&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017230&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525046341%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017230&amp;HITNO=6&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017230&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525046341%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Baltimore Business Journal:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017222&amp;HITNO=7&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017222&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525043373%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017222&amp;HITNO=7&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017222&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525043373%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pittsburgh Business Times:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017180&amp;HITNO=8&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017180&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525031362%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017180&amp;HITNO=8&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017180&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525031362%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Review Albany:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017000&amp;HITNO=9&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017000&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524971300%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017000&amp;HITNO=9&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017000&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524971300%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Kansas City Business Journal:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016975&amp;HITNO=10&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016975&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524962503%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016975&amp;HITNO=10&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016975&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524962503%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Birmingham Business Journal:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016648&amp;HITNO=11&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016648&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524829189%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016648&amp;HITNO=11&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016648&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524829189%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Puget Sound Business Journal:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016595&amp;HITNO=12&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016595&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524810283%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016595&amp;HITNO=12&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016595&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524810283%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Austin Business Journal:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016589&amp;HITNO=13&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016589&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524808958%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016589&amp;HITNO=13&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016589&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524808958%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Orlando Business Journal:</description></item>
<item><title>TenX Biopharma Licenses Zanolimumab From Genmab</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016586&amp;HITNO=14&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016586&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524808438%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016586&amp;HITNO=14&amp;MSIZE=51&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=BioVentures,%20Inc.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016586&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524808438%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Sacramento Business Journal:</description></item>
</channel></rss>